* Aspen Aerogels Inc ASPN.N reported a quarterly adjusted
loss
of 1 cent per share for the quarter ended in December, higher
than the same quarter last year, when the company reported EPS
of -20 cents. The mean expectation of nine analysts for the
quarter was for a loss of 12 cents per share. Wall Street
expected results to range from -13 cents to -10 cents per share.
* Revenue rose 41.3% to $84.22 million from a year ago;
analysts
expected $80.86 million.
* Aspen Aerogels Inc shares had fallen by 24.0% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 32.8%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the specialty
chemicals
peer group is also "buy"
Wall Street's median 12-month price target for Aspen Aerogels
Inc is $20.00
This summary was machine generated from LSEG data February 12 at
10:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.12 -0.01 Beat
Sep. 30 2023 -0.27 -0.19 Beat
Jun. 30 2023 -0.36 -0.22 Beat
Mar. 31 2023 -0.40 -0.24 Beat